Alder BioPharmaceuticals approaches rare status for a Seattle biotech

Bothell-based Alder BioPharmaceuticals, Inc. has an opportunity to do something pretty rare in Seattle, if its homegrown migraine drug gets approved by the Federal Drug Administration next year.